Berg T - Search Results

1

Association of TLR7 single nucleotide polymorphisms with chronic HCV-infection and response to interferon-a-based therapy.

Schott E, Witt H, Neumann K, Bergk A, Halangk J, Weich V, Müller T, Puhl G, Wiedenmann B, Berg T. Schott E, et al. Among authors: berg t. J Viral Hepat. 2008 Jan;15(1):71-8. doi: 10.1111/j.1365-2893.2007.00898.x. J Viral Hepat. 2008. PMID: 18088248

2

Treatment of chronic hepatitis C with interferon alpha: long-term follow-up and prognostic relevance of HCV genotypes.

Hopf U, Berg T, König V, Küther S, Heuft HG, Lobeck H. Hopf U, et al. Among authors: berg t. J Hepatol. 1996;24(2 Suppl):67-73. J Hepatol. 1996. PMID: 8836892 Clinical Trial.

3

Long-term efficacy of interferon alpha treatment in chronic hepatitis C.

Berg T, Kaul T, Heuft HG, Naumann U, Lobeck H, Wiedenmann B, Hopf U. Berg T, et al. J Hepatol. 1998 Sep;29(3):511-2. doi: 10.1016/s0168-8278(98)80076-7. J Hepatol. 1998. PMID: 9765005 Clinical Trial. No abstract available.

4

Dynamics of GB virus C viremia early after orthotopic liver transplantation indicates extrahepatic tissues as the predominant site of GB virus C replication.

Berg T, Müller AR, Platz KP, Höhne M, Bechstein WO, Hopf U, Wiedenmann B, Neuhaus P, Schreier E. Berg T, et al. Hepatology. 1999 Jan;29(1):245-9. doi: 10.1002/hep.510290121. Hepatology. 1999. PMID: 9862873 Clinical Trial.

5

Occurrence of a novel DNA virus (TTV) infection in patients with liver diseases and its frequency in blood donors.

Berg T, Schreier E, Heuft HG, Höhne M, Bechstein WO, Leder K, Hopf U, Neuhaus P, Wiedenmann B. Berg T, et al. J Med Virol. 1999 Sep;59(1):117-21. doi: 10.1002/(sici)1096-9071(199909)59:1<117::aid-jmv19>3.0.co;2-i. J Med Virol. 1999. PMID: 10440818

6

Mutations in the E2-PePHD and NS5A region of hepatitis C virus type 1 and the dynamics of hepatitis C viremia decline during interferon alfa treatment.

Berg T, Mas Marques A, Höhne M, Wiedenmann B, Hopf U, Schreier E. Berg T, et al. Hepatology. 2000 Dec;32(6):1386-95. doi: 10.1053/jhep.2000.20527. Hepatology. 2000. PMID: 11093746

7

[Effect of ribavirin on dynamics of hepatitis C viremia in interferon alpha-treated patiens with response or no response].

Berg T, Kaul T, Naumann U, Wiedenmann B, Hopf U. Berg T, et al. Z Gastroenterol. 2000 Nov;38(11):881-6. doi: 10.1055/s-2000-10299. Z Gastroenterol. 2000. PMID: 11132533 Clinical Trial. German.

8

Efficacy of a short-term ribavirin plus interferon alpha combination therapy followed by interferon alpha alone in previously untreated patients with chronic hepatitis C: a randomized multicenter trial.

Berg T, Hoffmann RM, Teuber G, Leifeld L, Lafrenz M, Baumgarten R, Spengler U, Zeuzem S, Pape GR, Hopf U. Berg T, et al. Liver. 2000 Dec;20(6):427-36. doi: 10.1034/j.1600-0676.2000.020006427.x. Liver. 2000. PMID: 11169056 Clinical Trial.

9

Pilot study of interferon-alpha high-dose induction therapy in combination with ribavirin plus amantadine for nonresponder patients with chronic hepatitis C.

Berg T, Naumann U, Wiedenmann B, Hopf U. Berg T, et al. Z Gastroenterol. 2001 Feb;39(2):145-51. doi: 10.1055/s-2001-11154. Z Gastroenterol. 2001. PMID: 11253505

10

Induction of T helper cell type 1 response and elimination of HBeAg during treatment with IL-12 in a patient with therapy-refractory chronic hepatitis B.

Barth H, Klein R, Berg PA, Wiedenmann B, Hopf U, Berg T. Barth H, et al. Among authors: berg t, berg pa. Hepatogastroenterology. 2001 Mar-Apr;48(38):553-5. Hepatogastroenterology. 2001. PMID: 11379352

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,264 results

Search Page

Filters